Patents by Inventor Marcel Mischler

Marcel Mischler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060275882
    Abstract: The invention relates to a process for producing a fermentation product wherein the viscosity of the mash is reduced by application of beta-glucanase and xylanase activity.
    Type: Application
    Filed: April 2, 2004
    Publication date: December 7, 2006
    Applicant: Novozymes
    Inventors: Ramiro Martinez-Gutierrez, Alain Destexhe, Hans Olsen, Marcel Mischler
  • Patent number: 5624835
    Abstract: The molecular characteristics and a partial amino acid sequence of an endo-.beta.-1,4-glucanase obtainable from Aspergillus aculeatus are described, as well as corresponding recombinant DNA sequences, vectors, and transformed hosts. Use of the endo-.beta.-1,4-glucanase or a pectinase preparation enriched with the endo-.beta.-1,4-glucanase for degradation or modification of plant cell walls is described.
    Type: Grant
    Filed: October 5, 1994
    Date of Patent: April 29, 1997
    Assignee: Novo Nordisk A/S
    Inventors: Kurt Dorreich, Flemming M. Christensen, Yvette Schnell, Marcel Mischler, Henrik Dalb.o slashed.ge, Hans P. Heldt-Hansen
  • Patent number: 5585256
    Abstract: The present invention relates to rhamnogalacturon acetyl esterases derived from Aspergillus aculeatus and DNA Sequences encoding the enzymes. The present invention also relates to the use of rhamnogalacturon acetyl esterases for degrading modified hairy region.
    Type: Grant
    Filed: October 5, 1994
    Date of Patent: December 17, 1996
    Assignee: Novo Nordisk A/S
    Inventors: Kurt Dorreich, Flemming M. Christensen, Yvette Schnell, Marcel Mischler, Henrik Dalb.o slashed.ge, Hans P. Heldt-Hansen
  • Patent number: 5474922
    Abstract: The present invention relates to .beta.-1,4-galactanase derived from A. aculeatus which have (a) a pH-optimum between 3.0 and 5.0, (b) an isoelectric point of 2.5-3.5, (c) a molecular weight of between 30,000 and 50,000, and (d) a temperature optimum between 10.degree. and 50.degree. C.
    Type: Grant
    Filed: July 15, 1993
    Date of Patent: December 12, 1995
    Assignee: Novo Nordisk A/S
    Inventors: Kurt Dorreich, Henrik Dalboge, Jan M. Mikkelsen, Marcel Mischler, Flemming M. Christensen